🇺🇸 FDA
Pipeline program

P276-00

P276-00/27/08

Phase 2 small_molecule completed

Quick answer

P276-00 for Melanoma is a Phase 2 program (small_molecule) at Piramal Critical Care B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Piramal Critical Care B.V.
Indication
Melanoma
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials